|
1
|
Li W, An X, Fu M and Li C: Emergency
treatment and nursing of children with severe pneumonia complicated
by heart failure and respiratory failure: 10 case reports. Exp Ther
Med. 12:2145–2149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen CH, Wen HJ, Chen PC, Lin SJ, Chiang
TL, Hsieh IC and Guo YL: Prenatal and postnatal risk factors for
infantile pneumonia in a representative birth cohort. Epidemiol
Infect. 140:1277–1285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin LJ, Wang YC and Liu XM: Clinical and
immunological features of common variable immunodeficiency in
China. Chin Med J (Engl). 128:310–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pancer KW: Problem of immunoglobulin M
co-detection in serological response to bacterial and viral
respiratory pathogens among children suspected of legionellosis.
Cent Eur J Immunol. 40:174–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Brien KL, Wolfson LJ, Watt JP, Henkle E,
Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS and
Cherian T; Hib and Pneumococcal Global Burden of Disease Study
Team, : Burden of disease caused by Streptococcus pneumoniae in
children younger than 5 years: Global estimates. Lancet.
374:893–902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chapman CG and Pekow J: The emerging role
of miRNAs in inflammatory bowel disease: A review. Therap Adv
Gastroenterol. 8:4–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meijer HA, Kong YW, Lu WT, Wilczynska A,
Spriggs RV, Robinson SW, Godfrey JD, Willis AE and Bushell M:
Translational repression and eIF4A2 activity are critical for
microRNA-mediated gene regulation. Science. 340:82–85. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schickel R, Boyerinas B, Park Sm and Peter
M: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao DD, Li L and Chan WY: MicroRNAs: Key
regulators in the central nervous system and their implication in
neurological diseases. Int J Mol Sci. 17:8422016. View Article : Google Scholar :
|
|
13
|
Oglesby IK, Mcelvaney NG and Greene CM:
MicroRNAs in inflammatory lung disease-master regulators or target
practice? Respir Res. 11:1482010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Plank M, Maltby S, Mattes J and Foster PS:
Targeting translational control as a novel way to treat
inflammatory disease: The emerging role of microRNAs. Clin Exp
Allergy. 43:981–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sato T, Shiba-Ishii A, Kim Y, Dai T, Husni
RE, Hong J, Kano J, Sakashita S, Iijima T and Noguchi M: miR-3941:
A novel microRNA that controls IGBP1 expression and is associated
with malignant progression of lung adenocarcinoma. Cancer Sci.
108:536–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berillo O, Régnier M and Ivashchenko A:
Binding of intronic miRNAs to the mRNAs of host genes encoding
intronic miRNAs and proteins that participate in tumourigenesis.
Comput Biol Med. 43:1374–1381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
18
|
Li W, Qiu X, Jiang H, Han Y, Wei D and Liu
J: Downregulation of miR-181a protects mice from LPS-induced acute
lung injury by targeting Bcl-2. Biomed Pharmacother. 84:1375–1382.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ke XF, Fang J, Wu XN and Yu CH:
MicroRNA-203 accelerates apoptosis in LPS-stimulated alveolar
epithelial cells by targeting PIK3CA. Biochem Biophys Res Commun.
450:1297–1303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu Z, Dong D, Chen X, Huang H and Wen S:
MicroRNA-381 negatively regulates TLR4 signaling in A549 cells in
response to LPS stimulation. Biomed Res Int. 2015:8494752015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dai R and Ahmed SA: MicroRNA, a new
paradigm for understanding immunoregulation, inflammation and
autoimmune diseases. Transl Res. 157:163–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamasaki T, Kim EJ, Cerutti H and Ohama T:
Argonaute3 is a key player in miRNA-mediated target cleavage and
translational repression in Chlamydomonas. Plant J. 85:258–268.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chao W and D'Amore PA: IGF2: Epigenetic
regulation and role in development and disease. Cytokine Growth
Factor Rev. 19:111–120. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Corkins MR, Gohil AD and Fitzgerald JF:
The insulin-like growth factor axis in children with inflammatory
bowel disease. J Pediatr Gastroenterol Nutr. 36:228–234. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matouk IJ, Halle D, Gilon M and Hochberg
A: The non-coding RNAs of the H19-IGF2 imprinted loci: A focus on
biological roles and therapeutic potential in lung cancer. J Transl
Med. 13:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jang HJ, Boo HJ, Lee HJ, Min HY and Lee
HY: Chronic stress facilitates lung tumorigenesis by promoting
exocytosis of IGF2 in lung epithelial cells. Cancer Res.
76:6607–6619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li P: Clinical significance of changes of
serum IGF-II, IL-2, IL-10 and TNF-α levels after treatment in
children with bronchopneumonia. J Radioimmunol. 19:288–289.
2006.
|
|
29
|
Qiu-qing D: Measurement of changes of
serum IGF-II, hs-CRP and M-CSF levels after treatment in pediatric
patients with bron-chopneumonia. J Huaihai Med. 6:112011.
|
|
30
|
McLaughlin KJ, Kochanowski H, Solter D,
Schwarzkopf G, Szabó PE and Mann JR: Roles of the imprinted gene
Igf2 and paternal duplication of distal chromosome 7 in the
perinatal abnormalities of androgenetic mouse chimeras.
Development. 124:4897–4904. 1997.PubMed/NCBI
|
|
31
|
Yamamoto K, Ferrari JD, Cao Y, Ramirez MI,
Jones MR, Quinton LJ and Mizgerd JP: Type I alveolar epithelial
cells mount innate immune responses during pneumococcal pneumonia.
J Immunol. 189:2450–2459. 2011. View Article : Google Scholar
|
|
32
|
Weichhart T and Säemann MD: The
PI3K/Akt/mTOR pathway in innate immune cells: Emerging therapeutic
applications. Ann Rheum Dis. 67 Suppl 3:iii70–iii74. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie S, Chen M, Yan B, He X, Chen X and Li
D: Identification of a role for the PI3K/AKT/mTOR signaling pathway
in innate immune cells. PLoS One. 9:e944962014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen XF, Zhang HJ, Wang HB, Zhu J, Zhou
WY, Zhang H, Zhao MC, Su JM, Gao W, Zhang L, et al: Transforming
growth factor-β1 induces epithelial-to-mesenchymal transition in
human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling
pathways. Mol Biol Rep. 39:3549–3556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chetty C, Lakka SS, Bhoopathi P and Rao
JS: MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated
PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer.
127:1081–1095. 2010. View Article : Google Scholar : PubMed/NCBI
|
